Previous Article | Next Article ![]()
Journal of Virology, January 2001, p. 125-133, Vol. 75, No. 1
Division of Molecular Biology, Institute for
Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20
7NN,1 and Department of Pathology,
Division of Virology, University of Cambridge, Cambridge CB2
1QP,2 United Kingdom
Received 26 June 2000/Accepted 6 October 2000
The parts of the RNA genome of infectious bronchitis virus (IBV)
required for replication and packaging of the RNA were investigated using deletion mutagenesis of a defective RNA (D-RNA) CD-61 (6.1 kb)
containing a chloramphenicol acetyltransferase reporter gene. A D-RNA
with the first 544, but not as few as 338, nucleotides (nt) of the 5'
terminus was replicated; the 5' untranslated region (UTR) comprises 528 nt. Region I of the 3' UTR, adjacent to the nucleocapsid protein gene,
comprised 212 nt and could be removed without impairment of replication
or packaging of D-RNAs. A D-RNA with the final 338 nt, including the
293 nt in the highly conserved region II of the 3' UTR, was replicated.
Thus, the 5'-terminal 544 nt and 3'-terminal 338 nt contained the
necessary signals for RNA replication. Phylogenetic analysis of 19 strains of IBV and 3 strains of turkey coronavirus predicted a
conserved stem-loop structure at the 5' end of region II of the 3' UTR.
Removal of the predicted stem-loop structure abolished replication of
the D-RNAs. D-RNAs in which replicase gene 1b-derived sequences had been removed or replaced with all the downstream genes were replicated well but were rescued poorly, suggesting inefficient packaging. However, no specific part of the 1b gene was required for efficient packaging.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.125-133.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
cis-Acting Sequences Required for
Coronavirus Infectious Bronchitis Virus Defective-RNA Replication
and Packaging


*
Corresponding author. Mailing address: Division of
Molecular Biology, Institute for Animal Health, Compton Laboratory,
Compton, Newbury, Berkshire RG20 7NN, United Kingdom. Phone: 44 1635 577273. Fax: 44 1635 577263. E-mail:
dave.cavanagh{at}bbsrc.ac.uk.
Present address: Department of Pathology, Yale University School of
Medicine, New Haven, CT 06510.
Present address: University of Cambridge, Department of
Haematology, Division of Transfusion Medicine, Cambridge CB2 2PT, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|